Breaking News

Envision's AI glasses aim to help visually impaired live independently

Not rendering correctly? View this email as a web page here.
EMERGE-MedCity-Leaderboard-728x90-1

Senators request GAO to proble Medicaid's low Covid vaccination rates

By Phil Galewitz, Kaiser Health News Monday, March 28, 2022 1:32 AM

Two prominent Democratic senators – Robert Casey Jr. of Pennsylvania and Ron Wyden of Oregon – have requested a Government Accountability Office study of why covid vaccination rates remain far lower among Medicaid enrollees than the general population.

Read more »

IBM dumping Watson Health is an opportunity to reevaluate artificial intelligence

By Shravani Durbhakula Sunday, March 27, 2022 12:00 PM

Artificial intelligence in healthcare is only as good as the patient data that is collected. The information must be accurate, and precision management of patient data is critical for AI to succeed.

Read more »

Envision aims to help visually impaired users live independently with updated AI-powered smart glasses

By Michael Schroeder Sunday, March 27, 2022 10:30 AM

Envision Glasses are designed with the aim of helping blind and visually impaired users better process text and the visual world around them, according to the company's co-founder, Karthik Kannan.

Read more »

Lessons learned from fighting HIV in Africa—and how they apply to Covid-19 in the U.S.

By Ernest Darkoh Sunday, March 27, 2022 9:00 AM

One of the most important lessons learned in Africa—and throughout the Covid-19 pandemic—is that data is your biggest ally. We need data to tell us what's going wrong and why. But most importantly, we need this information in real time.

Read more »

Data and regulatory roundup: Pfizer's feat, an ADHD miss, Eli Lilly's CRL & more

By Frank Vinluan Sunday, March 27, 2022 8:30 AM

A pharmaceutical giant reported a Phase 3 success for a potential blockbuster drug, while four other companies reported disappointing data from their respective clinical trials. Our recap of data readouts and regulatory news also includes one FDA rejection.

Read more »

   

No comments